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In this manuscript we present novel MRI approaches to dissecting axon vs. myelin
abnormalities in psychiatric disorders. Existing DTI approaches are not able to provide
specific information on these subcellular elements but novel approaches are beginning
to do so. We review two approaches (magnetization transfer ratio—MTR; and diffusion
tensor spectroscopy—DTS) and the theoretical framework for interpreting data derived
from these approaches. Work is ongoing to collect data that will answer some relevant
questions using these techniques in schizophrenia and related conditions.
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INTRODUCTION
Mental illnesses are common, debilitating, and at times fatal
(Kessler et al., 2005). Yet we know little about the pathophysiology
of many of these conditions and existing treatments are partially
effective and cause many side effects. Therefore, there is a great
need for better insights into the neurobiology of psychiatric con-
ditions and, as a corollary, for new treatment targets. Many lines
of evidence suggest that white matter (WM) abnormalities are
associated with psychiatric conditions. In fact, WM abnormalities
are common in bipolar disorder (Heng et al., 2010), major depres-
sive disorder (Arnone et al., 2012), and even attention deficit
and hyperactivity disorder (van Ewijk et al., 2012). But the most
pronounced and widespread abnormalities have been reported
in schizophrenia. Therefore, we will discuss schizophrenia as a
paradigmatic psychiatric disorder. In this review, we will discuss
some of the evidence for WM abnormalities in schizophrenia,
highlight what it can and cannot tell us about the biology and
discuss emerging alternative approaches to the problem.
Schizophrenia is typically diagnosed at a young age, is life-
long, and is among the leading causes of disability among people
aged 15–35 (Global Burden of Disease, 2006). The cost of the ill-
ness is high and the suffering of patients with SZ and that of their
families is great, as poor medication compliance, high rates of
substance use disorder comorbidity, and suicide rates near 10%
take their toll (Kessler et al., 2005). Despite its significance, rela-
tively little is known about the pathophysiology of schizophrenia.
Several lines of evidence suggest that integration of activity across
brain regions is as important as processing within any one brain
region. These include deficits in integration of activity in large-
scale neuronal networks (Garrity et al., 2007; Williamson, 2007;
Whitfield-Gabrieli et al., 2009), abnormalities in WM integrity
(Kubicki et al., 2007; Camchong et al., 2009), and in expres-
sion of myelin- and oligodendrocyte-related genes (Tkachev et al.,
2003). WM abnormalities are critical to conceptualization of SZ
as a dysconnection (abnormal connection) syndrome (Paus et al.,
2008; Stephan et al., 2009).
MRI-BASED PROBES OF WHITE MATTER INTEGRITY
Although several MR parameters reflect tissue properties, the
approach that is most widely used is diffusion MRI. As described
elsewhere in this issue, water molecular diffusion, referring to
the random translational (Brownian) motion of molecules, can
be examined in vivo using diffusion MRI. The MRI signal
decay when diffusion gradients are applied reflects the displace-
ment distribution of water molecules. Because diffusion of water
molecules is restricted by tissue components such as cell mem-
branes or macromolecules, diffusion MRI provides unique infor-
mation about the internal structure of brain tissue. In such
experiments, a diffusion tensor is calculated and this consists
of the three eigenvectors of diffusion arbitrarily labeled λ1, λ2,
and λ3 from largest to smallest. Diffusion MRI has already been
widely applied in the diagnosis and treatment of numerous brain
disorders, most importantly in ischemic stroke where a fall in
apparent diffusion coefficient [ADC; a.k.a. mean diffusivity =
(λ1 + λ2 + λ3)/3] of water molecules is seen within hours of the
ischemic event.
In the WM, water molecular diffusion takes place along the
fiber orientation direction [λ// or axial diffusivity (AD) = λ1]
to a much greater extent than perpendicular to it [λ⊥ or radial
diffusivity (RD) = (λ2+λ3)/2] (see Figure 1 for visual depiction
of λ1, λ2, and λ3). This process can be measured using diffu-
sion tensor imaging (DTI) where fractional anisotropy (FA—
derived from λ1, λ2, and λ3) reflects coherence of diffusion.
DTI has been used to demonstrate WM abnormalities in a vari-
ety of diseases including multiple sclerosis and schizophrenia.
FA reductions are commonly interpreted as reflecting loss of
“white matter integrity” but the exact nature of this loss cannot
be determined using DTI because the abnormality could arise
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from intra- or extracellular water. In addition, there is exchange
between the intra- and extracellular water compartments, making
it impossible to deduce the biological source of any abnormal-
ities. Therefore, reduced FA likely reflects different processes in
different disorders (such as demyelination, fiber crossing, axonal
swelling, or atrophy) (Alexander et al., 2007).
Despite these limitations, DTI studies have provided strong
evidence that WM integrity has great functional significance. For
example, variation in DTI measures in healthy populations has
been associated with cognitive processing speed (Turken et al.,
2008). In schizophrenia, FA reductions have been associated with
specific clinical presentations such as passivity phenomena (Sim
et al., 2009), auditory hallucinations (Shergill et al., 2007), or
positive symptoms more generally (Fujiwara et al., 2007), cogni-
tive functioning including working memory (Kubicki et al., 2003;
Karlsgodt et al., 2008), episodic memory (Nestor et al., 2004,
2008), executive function (Nestor et al., 2004, 2008; Rusch et al.,
2007; Takei et al., 2009), verbal learning (Takei et al., 2008), and
visuomotor performance (Perez-Iglesias et al., 2010), and with
fMRI connectivity measures (Schlosser et al., 2007; Spoletini et al.,
2009). Some similar findings have been reported in prodromal
individuals as well (Koutsouleris et al., 2010). This literature sug-
gests that WM integrity is highly relevant to specific domains of
brain function and dysfunction. In its current state, however, the
literature is weakened by the lack of a clear link between DTI and
WM biology (Kubicki et al., 2007) as evidenced by the absence
of a deeper biological understanding of WM abnormalities in
schizophrenia and of novel treatment targets.
FIGURE 1 | Schematic of proposed white matter measures.
NOVEL APPROACHES
The limitations of DTI as currently implemented in most centers
and for studying psychiatric conditions are widely acknowledged.
There are multiple approaches for extracting additional informa-
tion from the diffusion signal in order to generate novel biological
insights for psychiatric research. In this review, we provide a selec-
tive review of a two-pronged approach that focuses on axon and
myelin-related abnormalities separately. An extensive review of
all possibilities is far beyond the scope of this review. Instead, we
will primarily focus on the directions our research group is taking
and introduce concepts that are useful for understanding other
approaches and briefly describe some alternative approaches at
the end of the paper.
The two-pronged approach utilizes two recently developed
MR-based approaches to probe specific WM abnormalities: dif-
fusion tensor spectroscopy (DTS), and magnetization transfer
ratio (MTR). DTS is a diffusion MRI technique related to DTI
which measures the diffusion of intracellular metabolites such as
N-acetylaspartate (NAA) (see Figure 2). Because NAA is located
exclusively in neurons and almost exclusively in the cytosol (as
opposed to within organelles) (Tsai and Coyle, 1995), NAA dif-
fusion provides information about neuronal microstructure. The
ADC reflects the scalar distance traveled by a molecule in unit
time, and it is the easiest measure to interpret. In DTI studies
in schizophrenia, for example, water ADC elevations have been
reported accompanying the widespread water FA reductions dis-
cussed above (DeLisi et al., 2006; Andreone et al., 2007; Nenadic
et al., 2011). DTSmeasures have three very useful properties: first,
althoughmolecular diffusion can reflect either physical hindrance
by membranes or cytosol “viscosity,” data collection parameters
can be modified to ensure that we measure primarily the for-
mer (e.g., by increasing diffusion times and b-values). Second,
diffusion measures are independent of metabolite concentration.
Therefore, any metabolite concentration abnormalities do not
confound measures of metabolite diffusion. Third, ADC is sen-
sitive to axonal geometry and less to the macroscopic curvature
of WM tracts. If a voxel is placed at an angle to fiber direction
or if fibers zigzag instead of traveling straight, ADC will vary less
than FA or RD. This is because ADC is an average of the three
λ’s in the diffusion experiment and when fibers zigzag λ1 may
go down but λ2 and λ3 rise, leaving their average approximately
FIGURE 2 | Sample spectra acquired during the diffusion experiment.
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constant. In large voxel studies in vivomacroscopic curvature can
often be a factor. Therefore, even though RD is intuitively more
appropriate as an axon diameter measure, we focus on ADC.
DTS approaches have been implemented and validated in previ-
ous work in a variety of contexts, including as probes of cellular
diffusion (Ackerman and Neil, 2010) and for use in studies of
axon diameter in the healthy WM (Upadhyay et al., 2008). The
NAA DTS signal is informative: demyelination with preserved
axon geometry would lead to no NAAADC changes because NAA
diffusion within axons would be unaffected. By contrast, axon
diameter increase with preserved myelination would cause NAA
ADC change (see Figure 3). It is important to note that the argu-
ments presented above are relative, not absolute. NAA ADC can
be impacted by multiple axon geometry factors such as macro-
scopic curvature and not just by axon diameter. While we propose
that NAA ADC is useful in probing axonal geometry, it is only a
partial index of axon diameter specifically. This is particularly true
in brain regions such as the prefrontal cortex where there axons
are not tightly packed.
MTR is another MRI modality that has garnered recent atten-
tion. This approach relies on the exchange of magnetization
between water molecules in different physical environments. In
biological tissue, water molecules form a thin film aroundmacro-
molecules, including myelin lipids. The “bound” water molecules
in this film exchange protons with the “free” water molecules in
cytosol and this exchange can be measured using a magnetization
transfer paradigm where signal is saturated in one component
(e.g., bound water) and the loss of saturation in the other com-
ponent is measured (e.g., free water). The larger the amount
of myelin complement in WM, the larger the proton exchange
between bound and free water, and the higher the loss of signal
from free water. This loss of signal is quantified as MTR. MTR
FIGURE 3 | Proposed abnormalities in schizophrenia.
imaging is robust enough to be it is used in clinical settings to
improve contrast inWM anatomical imaging, especially in multi-
ple sclerosis.MTR is reported to be reduced in schizophrenia, sug-
gesting reduced myelin complement in this condition (Kubicki
et al., 2005) although a recent study was discrepant (Mandl et al.,
2008). The relationships between water DTI and NAA DTS signal
and longitudinal vs. radial diffusion as well as between MTR and
WMmicrostructure are summarized in the adjacent Figure 1.
AXON-MYELIN BALANCE
Total WM volume is determined by the number of axons, their
diameters, and the thickness of the myelin sheath around them.
Although these parameters are inter-related, they are can vary
partly independently. The importance of dissecting the processes
that contribute to WM changes was highlighted recently in the
context of normal human development. Increases in WM volume
during adolescence have been traditionally interpreted as reflect-
ing myelination but recent work using MTR showed that myelin
content does not rise measurably in boys despite the fact that their
WM volume increase is more pronounced than that of girls (Paus
et al., 2008; Perrin et al., 2008, 2009; Paus, 2010). This pattern
suggests that WM changes in male adolescence may be driven
by increases in axonal diameter and number as opposed to an
increase in the myelin complement.
The interplay between myelination and axon diameter is com-
plex. Myelination speeds up conduction of action potentials.
Larger axon diameters do the same, but the gain in conduction
speed with growing axon diameters is less than that obtained
from added myelination. Therefore, myelinated axons tend to be
of small diameter to allow physical space for extra myelin. There
appears to be a “sweet spot” for the ratio between axon diame-
ter and fiber diameter (axon diameter + myelin sheath thickness)
which maximizes conduction speeds. This is called the g-ratio
and is calculated at around 0.6 for the human brain (Kandel
et al., 1991; Chomiak and Hu, 2009; Paus and Toro, 2009). It is
known that the g-ratio changes during brain development based
on axonal electrical properties (Paus and Toro, 2009). In the
extreme case, organisms with no myelin in the nervous system
(such as the squid) have the largest axons, up to 1mm in diame-
ter (Chomiak andHu, 2009; Paus andToro, 2009). In pathological
conditions where myelination is partial or degraded, axons can
enlarge in diameter to compensate for reduced action potential
speed (Nave, 2010).
THE CHALLENGE
Although DTI has been a very useful tool for psychiatric research,
the ability to measure axon vs. myelin-related abnormalities sep-
arately in the WM is crucial for additional progress. DTI and
MTRhave been applied in schizophrenia, but there is no currently
available measure that is axon-specific. A tool that provides axon
specific along with myelin-related information would be valuable
in identifying biologically meaningful abnormalities in this con-
dition. MTR and DTS now provide this ability. In schizophrenia,
there is strong evidence for myelination abnormalities (Hakak
et al., 2001; Flynn et al., 2003; McCullumsmith et al., 2007;
Uranova et al., 2007) as well as suggestions of a mechanistic
relationship between developmental myelination abnormalities
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and schizophrenia (Budel et al., 2008). In addition, reductions in
NAA levels have been reported in the WM in schizophrenia, sug-
gesting a reduction in axonal packing density (Lim et al., 1998).
Axonal diameter abnormalities have not been reported but until
now these were only possible to measure in difficult postmortem
electron microscopy studies. Axonal health and myelination are
interrelated and abnormalities in one affect the other (Nave,
2010). Based on this literature we expect that application of DTS
and MTR measures simultaneously will detect abnormalities in
schizophrenia and in other psychiatric conditions. In this context,
MTR functions as a marker of myelination and the NAA ADC as
a marker of axonal geometry.
As reviewed above, correlation with cognitive and clinical
outcomes have been used extensively to establish the patho-
physiological significance of DTI abnormalities in schizophrenia.
Armed with myelin- and axon-specific measures ofWM integrity,
it also becomes possible to explore the significance of each in sim-
ilar fashion. For example, one would expect that cognitive tasks
dependent on prefrontal circuitry may correlate with MTR and
DTS measures obtained in the WM underlying the PFC. Another
complementary approach to provide additional face validity for
the combined MTR/DTS measures is the use of DTI to docu-
ment abnormalities in water diffusion. The MTS/DTS approach
can be used in conjunction with DTI (in fact, the water resonance
measured during the DTS experiment is analogous to DTI data).
Taken together, the MTR/DTS approach would improve upon
the existing paradigm of WM abnormalities in schizophrenia and
other psychiatric conditions in two ways. First, it allows us to dis-
sect the oft-repeated phrase “abnormal WM integrity” into com-
ponent parts and examine how different changes in WM integrity
can have different consequences. In fact, some WM alterations
may be salutary ones as a compensation for upstream abnormal-
ities. In this regard, the complex picture concerning WM changes
during male vs. female adolescence discussed above provides a
glimpse into how this proposal may challenge current paradigms
of WM abnormality in psychiatry. Second, it offers concrete
and measureable predictions about the impact of WM abnor-
malities on signal conduction in schizophrenia. I.e., “disrupted
WM integrity” cannot correlate with conduction speed but axon
geometry and myelin sheath thickness can. Although many have
noted that WM abnormalities in schizophrenia must have func-
tional consequences (Kubicki et al., 2007), the link between DTI
measures and brain function remains abstract (Whitford et al.,
2012).
Despite great interest in the role WM abnormalities play in
cognitive function in psychiatric conditions, we do not yet have
WM treatment targets. This is partly because existing measures of
WMabnormalities are underdetermined, i.e., severalmechanisms
could lead to the same result. Therefore, we do not know which
biological mechanisms are responsible for the WM alterations
seen in schizophrenia. We propose that the MTR/DTS measure
will offer meaningful biomarkers for this critical process.
There is a lengthy and productive history of studying post-
mortem tissue to probe WM abnormalities in psychiatry (e.g.,
Benes et al., 1987; Akbarian et al., 1993; Selemon and Goldman-
Rakic, 1999), but in vivo neuroimaging tools have not been
applied systematically to this problem except through the use of
DTI. In addition, inherent problems with fixation often limit the
application of electron microscopy to many postmortem human
brain samples. Abnormalities in axons and in myelin have been
reported, but we have had no ability to detect or monitor these
in vivo. Although the application of MRI to histology has been
discussed previously as “magnetic resonance microscopy” (Mori
and Zhang, 2006; Mori et al., 2006), these ideas have not yet been
expanded to human psychiatric disorders. Our vision is to expand
MTR/DTS and related approaches into a “toolbox” measuring
several aspects of the brainmicroenvironment in clinically accept-
able scan times. To bemaximally useful, this toolbox would collect
regionally-specific data from voxels within gray matter (GM) and
WM, and would include T1 and T2 relaxation times (Ongur
et al., 2010) and perhaps other measures as well as MTR/DTS.
Although this is a challenge with current technology, increasing
field strengths and improving technical approaches are increas-
ingly making it possible to use neuroimaging to probe parameters
previously accessible only to postmortem research.
MAGNETIZATION TRANSFER RATIO (MTR) SPECTROSCOPY
We have implemented the MTR sequence on the 4T Varian
scanner atMcLeanHospital and collected MTRdata from a phan-
tom preparation containing an aqueous NaCl-solution. The MTR
experiment relies on measuring the total magnitude water signal
in the presence and absence of a BISTRO saturation pulse. The
water signal magnitude is maximal without the saturation pulse.
The pulse causes saturation of signal coming from “bound” water
molecules. Because there is transfer between “bound” and “free”
water molecules, the saturation pulse measurably attenuates the
signal coming from “free” water molecules. Figure 4 shows the
MTR measured after a saturation pulse is applied at resonances
near the main water resonance (normalized to a non-pulse inten-
sity of 1.0). The lower curve represents measurements made in
the aqueous solution phantom where there are no “bound” water
molecules. When the saturation pulse is applied at most frequen-
cies the MTR is zero, but it rises when the pulse is positioned right
on the water frequency (i.e., it saturates all water molecule reso-
nances). The data points from a healthy control collected from
FIGURE 4 | Magnetization transfer ratio data.
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a 1 × 3 × 3 cm (9 cc) voxel in the WM underlying the right PFC
show that, as expected, the saturation pulse causes a rise in MTR
even when it is off-resonance in the human brain. This is because
there are “bound” water molecules in vivo interacting with lipids
and proteins and these are affected by the off-resonance sat-
uration pulse. Their chemical exchange with the “free” water
molecules causes a loss of water signal intensity. The MTR can
be calculated based on water signal intensity acquired in presence
(Ms) and absence (Mc) of the BISTRO saturation pulse [MTR =
(Mc-Ms)/Mc].
Compared to DTI, MTR is equally quick to obtain whole brain
data. But the two techniques measure different processes, each
with its own limitations. Therefore, the two techniques are best
considered complementary.
DTS
We have also implemented DTS measurements of water and
metabolites on the same 4T Varian scanner at McLean from
the same 9 cc right PFC WM voxel in the human brain. DTS
measurements in a phantom preparation demonstrated isotropic
diffusion and these measures were used to calibrate diffusion gra-
dient strength (b-value). The voxel location is identical to that in
the MTR experiments. The seven spectra obtained during a DTS
experiment are shown in Figure 2 with the NAA peak highlighted
in select spectra. Note that we show water-suppressed spectra
here for simplicity, although we also collected water unsuppressed
spectra which allow us to calculate water ADC and FA. From these
spectra are calculated the three diffusion eigenvalues and subse-
quently the ADC, RD, AD, and FA. The units for the diffusion
data are mm2/s ×10−3. The water FA and ADC and the NAA FA
and ADC values we calculate for a healthy control are similar to
those in other DTI and DTS studies (e.g., Upadhyay et al., 2008;
Camchong et al., 2009). Specifically, NAA is a larger molecule
and diffuses more slowly than water so it has a lower ADC.
Furthermore, two observations confirm that NAA has the dif-
fusion properties of an intracellular metabolite while water does
not: NAA FA is much higher than water FA; and the NAA AD/RD
ratio is higher than the water AD/RD ratio. Being restricted
within axons would increase FA and the AD/RD ratio, exactly
as seen with NAA. The findings for creatine and choline (two
other intracellular metabolites which are quantified with DTS)
were similar to those for NAA. The metabolite diffusion param-
eters measured in a sample of 10 healthy individuals are listed in
Table 1 below. These studies showcase our ability to implement
a cutting-edge MRI sequence at 4T and to collect data on WM
microstructure.
Compared to DTI, DTS collects data more slowly and from
a single large voxel (as opposed to small voxels with whole
brain coverage in DTI). These shortcomings are balanced by the
Table 1 | Diffusion data in the healthy human white matter.
RD AD ADC FA
NAA 0.16 ± 0.04 0.41 ± 0.09 0.24 ± 0.04 0.55 ± 0.15
Cr 0.15 ± 0.04 0.40 ± 0.08 0.23 ± 0.03 0.58 ± 0.18
Cho 0.15 ± 0.04 0.43 ± 0.10 0.24 ± 0.05 0.60 ± 0.10
different information offered by DTS—the diffusion properties
of NAA are dependent on axon geometry and this information
is complementary to the water diffusion information garnered
using DTI.
ALTERNATIVE APPROACHES
Some shortcomings of the single-voxel MTR/DTS approach
would be remedied if we could collect data from the entire brain
as is done in DTI studies. This is possible for MTR but not for
DTS currently because metabolites such as NAA are present in
the brain at about 1:5000 the concentration of water (approxi-
mately 10mM vs. 50M). This dramatically reduced signal forces
us to collect data from a larger voxel and to carry out more rep-
etitions for each data point to reach acceptable signal-to-noise
ratios. Chemical shift imaging approaches have been described
which can collect high quality MRS data from the entire brain
(Posse et al., 2007; Maudsley et al., 2009) but these have not yet
been combined with diffusion gradients. We plan to explore this
combination but we recognize that this may not be possible given
the SNR limitations.
Another concern with our DTS approach is that the NAA sig-
nal we measure in our experiments contains contributions from
NAA and N-acetylaspartylglutamate (NAAG). NAAG is located
both intra- and extracellularly (Coyle, 1997) and our DTS mea-
sures may be confounded by this contamination. NAAG is very
similar to NAA in chemical structure so the two MRS signals are
challenging to resolve using regular PRESS approaches. NAAG
concentration in the PFC WM is 1.5mM in healthy individu-
als (of which an unknown fraction is extracellular) (Pouwels and
Frahm, 1997) whereas NAA concentrations are usually calculated
at about 10mM (Govindaraju et al., 2000). Therefore, we do not
expect this to be a major factor in our work.
Finally MTR, although sensitive, is not a specific measure of
myelin content. Concerns have been raised that MTR abnor-
malities can arise from acute inflammation, edema, and other
processes that impact brainwater content (Laule et al., 2007). This
issue limits the utility of MTR in pathologies where gross abnor-
malities in brain water content are seen. There is no evidence
for such gross abnormalities in psychiatric disorders and past
applications of MTR in schizophrenia have been consistent with
subtle myelination-related changes (Kubicki et al., 2005). Others
have proposed a more specific measure of WM myelin content
which takes advantage of the differential T2 relaxation proper-
ties of water trapped within myelin vs. free water (MacKay et al.,
2006). This approach may be desirable because it would be more
specific to myelin content, but it is more technically challenging
to implement. The T2-based approach requires using ultrashort
echo times (5ms or shorter) which in turn require optimization
of both hardware (amplifiers, transmit-receive switches) and soft-
ware (e.g., STEAM sequences as opposed to our usual PRESS
sequences).
There are also alternatives to the DTS approach, e.g., by opti-
mizing the water diffusion experiment parameters for measuring
axon diameter. Since the water signal is so much larger, such
data could theoretically be collected in a shorter time than DTS.
One such approach (termed AxCaliber) is in fact in early stages
of development but thus far it has only been validated in vitro
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(Assaf et al., 2008). Unfortunately AxCaliber requires sequences
to be repeated over very long scan times—and as a result is
not available yet for clinical studies. Other approaches are also
being developed (Zhang et al., 2011; Dyrby et al., 2012). Thus,
we believe the single voxel DTS approach currently represents the
state-of-the-art for examining changes in axon geometry.
CONCLUSIONS
A better understanding of WM abnormalities would be critical
for the development of better treatments for common psychiatric
conditions. Although DTI has shown us that these conditions are
characterized by reduced WM integrity, it cannot tell us whether
the abnormality is in axons, myelin, or both. This information
is relevant because signal transduction in the WM depends on
the relative health of these two compartments. Recently devel-
oped techniques such as MTR and DTS allow us to dissect signal
from these two compartments, which would in principle help
us quantify their relative abnormalities in psychiatric conditions.
Many challenges remain, foremost among them the limitation
of DTS data collection to a single large voxel and the difficulty
of interpreting DTS signal from such large voxels. But future
clinical studies will give us more detailed information on WM
abnormalities in schizophrenia and other conditions than we
have previously had access to. In addition, the application of
these methods can extend beyond psychiatric disorders to study
of aging and gender comparisons which may have additional
implications for cross sectional and longitudinal evaluations in
psychiatric studies.
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